Company profile
Kidney Transplant | Discard Rates | Medical Device
Accunea is the world's first company to use real-time biosensing technology to reduce kidney transplant discard and failure rates. Making sure every organ counts.
Financial period: 1 Apr 2023 to 31 Mar 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
DISS40 | Transaction MzUxMzcwNTIwOGFkaXF6a2N4 | Paper/PDF filed
Published 01 Apr 2026 23:06
DISS16(SOAS) | Transaction MzUxMzYzOTY0OGFkaXF6a2N4 | Paper/PDF filed
Published 01 Apr 2026 22:57
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Nov 2018 to 31 Oct 2019
"Across the world today, one fifth of all hospital patients will suffer a kidney injury, and one quarter of these patients will die from this. In the UK alone kidney injury is responsible for an excess of 40,000 deaths per year, and £1bn of NHS spending. We can change this. We have invented a portable bedside chemical analysis device which continuously mo...
